KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.

  • Bausch Health Companies' Operating Expenses fell 593.07% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 billion, marking a year-over-year increase of 9.85%. This contributed to the annual value of $8.1 billion for FY2024, which is 365.67% up from last year.
  • Latest data reveals that Bausch Health Companies reported Operating Expenses of $2.1 billion as of Q3 2025, which was down 593.07% from $2.1 billion recorded in Q2 2025.
  • Bausch Health Companies' 5-year Operating Expenses high stood at $2.4 billion for Q4 2022, and its period low was $1.5 billion during Q3 2021.
  • Over the past 5 years, Bausch Health Companies' median Operating Expenses value was $2.0 billion (recorded in 2024), while the average stood at $2.0 billion.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 4015.38% in 2021, then tumbled by 2735.77% in 2022.
  • Quarter analysis of 5 years shows Bausch Health Companies' Operating Expenses stood at $1.8 billion in 2021, then skyrocketed by 32.8% to $2.4 billion in 2022, then decreased by 15.77% to $2.0 billion in 2023, then fell by 2.2% to $2.0 billion in 2024, then increased by 3.05% to $2.1 billion in 2025.
  • Its Operating Expenses stands at $2.1 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $2.0 billion for Q1 2025.